跳至主要内容
临床试验/NCT01704638
NCT01704638已完成1 期

Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Cmax of fluvoxamine and of digoxin

研究概览

简要总结

The investigators will compare plasma kinetics of two marker drugs in individuals with different genetic variations in the MDR1-gene. The hypothesis is that one group will have higher exposure than the other.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Healthy volunteer ≥ 18 years of age
  • Normal kidney function as measured by GFR according to Cockroft-Gault (70-120 ml/min)
  • Normal P-potassiumvalue (3,6-4,6 mmol/L)
  • HF>50 and no AV-block on resting ECG. No other significant abnormalities as judged by the investigator.
  • Subject giving written informed consent
  • Subject capable of understanding instructions

排除标准

  • - Pregnancy
  • Ongoing infection
  • Intake of medication, including natural remedies (for example St John´s wort), within one month prior to starting study except for paracetamol.
  • Active drug or alcohol abuse

研究组 & 干预措施

2677GG

Other

plasma kinetics of fluvoxamine and digoxin in this genotype

干预措施: fluvoxamine (Drug)

2677GG

Other

plasma kinetics of fluvoxamine and digoxin in this genotype

干预措施: Digoxin (Drug)

2677TT

Experimental

Plasma kinetics of fluvoxamine and digoxin in this genotype

干预措施: fluvoxamine (Drug)

2677TT

Experimental

Plasma kinetics of fluvoxamine and digoxin in this genotype

干预措施: Digoxin (Drug)

结局指标

主要结局

Cmax of fluvoxamine and of digoxin

时间窗: 2 days for fluvoxamine and 2 days for digoxin. Washout period of at least 1 week between the both parts. Total study time maximum 4 weeks.

The participants are administered a single dose of fluvoxamine or digoxin. Plasma kinetics of fluvoxamine are followed for 36 hours. Plasma kinetics of digoxin are followed for 48 hours. There is a washout period between the both parts.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erik Sparve

MD, specialist in clinical pharmacology

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验

Kinetics of Fluvoxamine and Digoxin in Subjects With... | 临床试验